
Feb 13, 2025, 17:00
Myeloma Paper of the Day, February 12th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: CAR+ T-cell lymphoma after cilta-cel therapy for relapsed or refractory myeloma that developed in two patients treated on the phase 3 CARTITUDE-4 trial who had evidence of detectable CAR transgene expression and integration.”
“CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma”
Authors: Simon Harrison, Cyrille Touzeau, Nicolas Kint, Benoit Tessoulin, Piers Blombery et al.
More posts featuring Robert Orlowski.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 14, 2025, 01:08
Apr 13, 2025, 18:24
Apr 13, 2025, 18:15
Apr 13, 2025, 17:15
Apr 13, 2025, 16:53
Apr 13, 2025, 16:17